BioTime
Regenerative medicine, reinvented.
- Home
- Company
- Products
- Investors
- Subsidiaries
- Regenerative Medicine
About BioTime
BioTime is a biotechnology company focused on the emerging field of regenerative medicine. Our core technologies center on novel stem cells capable of becoming all of the cell types in the human body. Products made from these “pluripotent” stem cells are being developed by our subsidiaries, each of which concentrates on different medical specialties, including: neuroscience, oncology, orthopedics, and blood and vascular diseases. BioTime’s commercial strategy targets near-term commercial opportunities such as Hextend and our current line of research products: ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, and GMP human embryonic stem cell lines. In addition, the launch of HyStem-Rx as a cell delivery device is expected in 2013, and the launch of PanC-Dx as a novel blood-based cancer screen is expected by 2014.
Latest News
SimpleXMLElement Object
(
[@attributes] => Array
(
[CorpMasterID] => 83805
)
[NewsReleases] => SimpleXMLElement Object
(
[@attributes] => Array
(
[PubDate] => 20120529
[PubTime] => 02:05:57
)
[NewsRelease] => Array
(
[0] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1699020
[DLU] => 20120523 12:45:29
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.08
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/23/2012 8:45:29 AM
[DisplayDateStart] => May 23 2012 08:45
[DisplayDateEnd] => May 23 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[1] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1698562
[DLU] => 20120522 12:45:22
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/22/2012 8:45:21 AM
[DisplayDateStart] => May 22 2012 08:45
[DisplayDateEnd] => May 22 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[2] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1697986
[DLU] => 20120521 12:45:22
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/21/2012 8:45:22 AM
[DisplayDateStart] => May 21 2012 08:45
[DisplayDateEnd] => May 21 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[3] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1695478
[DLU] => 20120514 12:46:02
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => HyStem(R)-C
Demonstrated Effective when Formulated with Human Heart Cells and
Transplanted in an Animal Model of Heart Disease
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/14/2012 8:46:02 AM
[DisplayDateStart] => May 14 2012 08:46
[DisplayDateEnd] => May 14 2032 12:46
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[4] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1694983
[DLU] => 20120511 22:25:53
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 1
)
[Title] => BioTime Announces First Quarter 2012 Financial Results and Recent Corporate Accomplishments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/10/2012 9:53:00 PM
[DisplayDateStart] => May 11 2012 06:25
[DisplayDateEnd] => May 11 2032 01:53
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[5] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686088
[DLU] => 20120426 17:40:17
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary LifeMap Sciences, Inc. Presents Update on Product Development
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 3:31:00 PM
[DisplayDateStart] => Apr 26 2012 01:40
[DisplayDateEnd] => Apr 23 2032 07:31
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[6] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686072
[DLU] => 20120426 17:41:24
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary ReCyte Therapeutics, Inc. Provides Update on Preclinical Development of Vascular Progenitors for the Treatment of Age-Related Vascular Disease
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 2:33:00 PM
[DisplayDateStart] => Apr 26 2012 01:41
[DisplayDateEnd] => Apr 23 2032 06:33
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[7] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686071
[DLU] => 20120426 17:39:32
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and its Subsidiary OrthoCyte Corporation Provides Update on Preclinical Development of OTX-CP07
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 2:33:00 PM
[DisplayDateStart] => Apr 26 2012 01:39
[DisplayDateEnd] => Apr 23 2032 06:33
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[8] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686065
[DLU] => 20120423 19:09:23
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary OncoCyte Corporation Provides Update on PanC-DxTM, and Related Diagnostic Products
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 2:24:00 PM
[DisplayDateStart] => Apr 23 2012 03:09
[DisplayDateEnd] => Apr 23 2032 06:24
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[9] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686051
[DLU] => 20120423 18:15:17
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on
OpRegen(R) Product Development
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 2:15:17 PM
[DisplayDateStart] => Apr 23 2012 02:15
[DisplayDateEnd] => Apr 23 2032 06:15
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[10] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1686045
[DLU] => 20120423 18:03:17
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Provides Update on ReneviaTM Product
Development
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 2:03:17 PM
[DisplayDateStart] => Apr 23 2012 02:03
[DisplayDateEnd] => Apr 23 2032 06:03
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[11] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1685878
[DLU] => 20120423 13:16:53
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Demonstrates Efficient Method for the Manufacture of
Cartilage-Producing Cells from Human Embryonic Stem Cells
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/23/2012 9:16:53 AM
[DisplayDateStart] => Apr 23 2012 09:16
[DisplayDateEnd] => Apr 23 2032 01:16
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[12] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1685464
[DLU] => 20120420 12:46:39
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and Subsidiary LifeMap Sciences Announce Agreement to Acquire
XenneX, Inc.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/20/2012 8:46:39 AM
[DisplayDateStart] => Apr 20 2012 08:46
[DisplayDateEnd] => Apr 20 2032 12:46
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[13] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1684387
[DLU] => 20120418 12:46:34
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at the Future Leaders in the
Biotech Industry Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/18/2012 8:46:34 AM
[DisplayDateStart] => Apr 18 2012 08:46
[DisplayDateEnd] => Apr 18 2032 12:46
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[14] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1683258
[DLU] => 20120416 12:57:41
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at the 8th
GTC Stem Cell Summit 2012
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/16/2012 8:57:41 AM
[DisplayDateStart] => Apr 16 2012 08:57
[DisplayDateEnd] => Apr 16 2032 12:57
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[15] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1682385
[DLU] => 20120412 12:47:01
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Board of Directors Forms Science and Technology Committee
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/12/2012 8:47:01 AM
[DisplayDateStart] => Apr 12 2012 08:47
[DisplayDateEnd] => Apr 12 2032 12:47
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[16] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1675344
[DLU] => 20120322 12:45:13
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/22/2012 8:45:13 AM
[DisplayDateStart] => Mar 22 2012 08:45
[DisplayDateEnd] => Mar 22 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[17] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1675125
[DLU] => 20120321 20:14:47
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at 2012 Maxim Group Growth Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/21/2012 4:14:47 PM
[DisplayDateStart] => Mar 21 2012 04:14
[DisplayDateEnd] => Mar 21 2032 08:14
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[18] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1672906
[DLU] => 20120315 00:12:58
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/14/2012 6:58:00 PM
[DisplayDateStart] => Mar 14 2012 08:12
[DisplayDateEnd] => Mar 14 2032 10:58
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[19] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1671061
[DLU] => 20120308 23:04:51
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime to Present at ROTH 24th Annual Growth Stock Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/8/2012 6:04:51 PM
[DisplayDateStart] => Mar 08 2012 06:04
[DisplayDateEnd] => Mar 08 2032 11:04
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[20] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1662599
[DLU] => 20120217 19:08:25
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at New York Stem Cell Summit
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 2/17/2012 2:08:24 PM
[DisplayDateStart] => Feb 17 2012 02:08
[DisplayDateEnd] => Feb 17 2032 07:08
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[21] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1651750
[DLU] => 20120125 18:14:00
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem Cell Reprogramming from The Wistar Institute
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/24/2012 8:45:00 AM
[DisplayDateStart] => Jan 25 2012 01:14
[DisplayDateEnd] => Jan 24 2032 01:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => Array
(
[0] => oncocyte
[1] => recyte
)
)
)
[22] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1644006
[DLU] => 20120103 13:45:37
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime to Produce Stem Cells for Research in Muscle Disorders
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/3/2012 8:45:36 AM
[DisplayDateStart] => Jan 03 2012 08:45
[DisplayDateEnd] => Jan 03 2032 01:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[23] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1641768
[DLU] => 20120105 23:27:08
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Signs Agreement with USCN Life Science to Source Antibody-Based Products
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/21/2011 8:45:00 AM
[DisplayDateStart] => Jan 05 2012 06:27
[DisplayDateEnd] => Dec 21 2031 01:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => Array
(
[0] => lifemap
[1] => oncocyte
)
)
)
[24] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1640465
[DLU] => 20111216 13:46:48
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary OncoCyte Corporation Announces Plans for the
Novel Pan-Cancer Diagnostic Product PanC-DxTM
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/16/2011 8:46:48 AM
[DisplayDateStart] => Dec 16 2011 08:46
[DisplayDateEnd] => Dec 16 2031 01:46
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => oncocyte
)
)
[25] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1638603
[DLU] => 20111212 13:45:52
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/12/2011 8:45:52 AM
[DisplayDateStart] => Dec 12 2011 08:45
[DisplayDateEnd] => Dec 12 2031 01:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[26] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1634181
[DLU] => 20111129 13:46:25
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of
Directors
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/29/2011 8:46:24 AM
[DisplayDateStart] => Nov 29 2011 08:46
[DisplayDateEnd] => Nov 29 2031 01:46
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[27] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1629845
[DLU] => 20111114 13:45:25
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Cell Information Now Available in GeneCards(R)
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/14/2011 8:45:24 AM
[DisplayDateStart] => Nov 14 2011 08:45
[DisplayDateEnd] => Nov 14 2031 01:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[28] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1628477
[DLU] => 20111109 15:27:37
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Third Quarter 2011 Financial Results and Recent Corporate Accomplishments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/8/2011 10:26:00 AM
[DisplayDateStart] => Nov 09 2011 10:27
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[29] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626438
[DLU] => 20111104 13:13:50
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present Keynote Address at Translational Strategies for Tissue Engineering Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/25/2011 8:55:00 AM
[DisplayDateStart] => Nov 04 2011 09:13
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[30] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626439
[DLU] => 20111104 13:14:34
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Publishes Paper Describing First Complete Sequencing of the Nuclear DNA of Five Clinical-Grade Human Embryonic Stem Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/13/2011 9:13:00 AM
[DisplayDateStart] => Nov 04 2011 09:14
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[31] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626441
[DLU] => 20111104 13:16:08
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at GTC 2011 5th Advances in Stem Cell Discovery & Development Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/10/2011 9:14:00 AM
[DisplayDateStart] => Nov 04 2011 09:16
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[32] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626442
[DLU] => 20111104 13:16:49
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Appointment of Chief Financial Officer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/4/2011 9:16:00 AM
[DisplayDateStart] => Nov 04 2011 09:16
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[33] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626443
[DLU] => 20111104 13:21:55
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at 2011 World Stem Cell Summit
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/29/2011 9:16:00 AM
[DisplayDateStart] => Nov 04 2011 09:21
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[34] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626444
[DLU] => 20111104 13:22:30
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2011
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/12/2011 9:21:00 AM
[DisplayDateStart] => Nov 04 2011 09:22
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[35] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626445
[DLU] => 20111104 13:23:11
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Enters into Worldwide License Agreement with Cornell University to Develop and Commercialize Vascular Cells Derived from Human Embryonic Stem Cells
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/6/2011 9:22:00 AM
[DisplayDateStart] => Nov 04 2011 09:23
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[36] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626446
[DLU] => 20111104 13:23:52
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael D. West to Present at Rodman & Renshaw 13th Annual Healthcare Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/1/2011 9:23:00 AM
[DisplayDateStart] => Nov 04 2011 09:23
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[37] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626447
[DLU] => 20111212 20:51:38
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's Subsidiary OncoCyte Corporation Expands Cancer Programs with $10 Million Equity Financing
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/24/2011 9:23:00 AM
[DisplayDateStart] => Dec 12 2011 03:51
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => oncocyte
)
)
[38] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626449
[DLU] => 20111104 13:28:42
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Receives NIH Approval for Four GMP Human Embryonic Stem Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/19/2011 9:24:00 AM
[DisplayDateStart] => Nov 04 2011 09:28
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[39] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626450
[DLU] => 20111104 13:29:22
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Second Quarter 2011 Financial Results and Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/9/2011 9:28:00 AM
[DisplayDateStart] => Nov 04 2011 09:29
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[40] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626451
[DLU] => 20111104 13:29:59
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at the Agora Financial Investment Symposium 2011
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/21/2011 9:29:00 AM
[DisplayDateStart] => Nov 04 2011 09:29
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[41] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626452
[DLU] => 20111104 13:30:37
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces the Issuance of a Second U.S. Glycosan Hydrogel Patent
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/19/2011 9:29:00 AM
[DisplayDateStart] => Nov 04 2011 09:30
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[42] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626458
[DLU] => 20111104 13:31:46
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Receives $335,900 SBIR Grant
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/15/2011 9:30:00 AM
[DisplayDateStart] => Nov 04 2011 09:31
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[43] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626459
[DLU] => 20111104 13:32:38
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Appointment of Chief Commercial Officer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/29/2011 9:31:00 AM
[DisplayDateStart] => Nov 04 2011 09:32
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[44] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626460
[DLU] => 20111104 13:33:54
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Reports First Complete Sequencing of the Nuclear Genome of Five GMP-Compliant Human Embryonic Stem Cell Lines at Jefferies 2011 Global Healthcare Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/9/2011 9:32:00 AM
[DisplayDateStart] => Nov 04 2011 09:33
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[45] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626461
[DLU] => 20111104 13:37:41
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Receives NIH Approval for Two GMP Human Embryonic Stem Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/3/2011 9:33:00 AM
[DisplayDateStart] => Nov 04 2011 09:37
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[46] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626464
[DLU] => 20111104 13:41:08
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at the Jefferies 2011 Global Healthcare Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/2/2011 9:37:00 AM
[DisplayDateStart] => Nov 04 2011 09:41
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[47] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626465
[DLU] => 20111104 13:43:19
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Issuance of U.S. Glycosan Hydrogel Patent
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/10/2011 9:41:00 AM
[DisplayDateStart] => Nov 04 2011 09:43
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[48] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626466
[DLU] => 20111104 13:44:10
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces First Quarter 2011 Financial Results and Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/5/2011 9:43:00 AM
[DisplayDateStart] => Nov 04 2011 09:44
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[49] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626480
[DLU] => 20111104 14:08:17
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Initiates Clinical Development Program for HyStem®-Rx as a Cell Delivery Device for Reconstructive Surgery and Other Cell-Based Therapies
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/3/2011 9:44:00 AM
[DisplayDateStart] => Nov 04 2011 10:08
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[50] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626481
[DLU] => 20111104 14:08:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/12/2011 10:08:00 AM
[DisplayDateStart] => Nov 04 2011 10:08
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[51] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626482
[DLU] => 20111212 20:43:10
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/5/2011 10:08:00 AM
[DisplayDateStart] => Dec 12 2011 03:43
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => lifemap
)
)
[52] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626483
[DLU] => 20111212 20:52:36
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/22/2011 10:09:00 AM
[DisplayDateStart] => Dec 12 2011 03:52
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => orthocyte
)
)
[53] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626485
[DLU] => 20111104 14:11:53
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/15/2011 10:11:00 AM
[DisplayDateStart] => Nov 04 2011 10:11
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[54] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626486
[DLU] => 20111104 14:12:27
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Michael West to Present at French-American Biotech Symposium, San Francisco, April 11-12, 2011
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/4/2011 10:11:00 AM
[DisplayDateStart] => Nov 04 2011 10:12
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[55] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626487
[DLU] => 20111212 20:53:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Agreement To Acquire Glycosan BioSystems
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 2/14/2011 10:12:00 AM
[DisplayDateStart] => Dec 12 2011 03:53
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => orthocyte
)
)
[56] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626488
[DLU] => 20111212 20:52:09
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Acquires Assets of Cell Targeting, Inc.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/28/2011 10:13:00 AM
[DisplayDateStart] => Dec 12 2011 03:52
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => oncocyte
)
)
[57] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627065
[DLU] => 20111107 15:10:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Launches New Stem Cell Lines in Anticipation of President Obama's Removal of Restrictions on Federal Funding of Embryonic Stem Cell Research
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/21/2011 10:09:00 AM
[DisplayDateStart] => Nov 07 2011 10:10
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[58] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626489
[DLU] => 20111104 14:14:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's CEO Michael West to Present Preclinical Data on OTX-CP03 and OTX-CP07 for the Treatment of Osteoarthritis at STEM 2011 in Gurgaon, India
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/10/2011 10:13:00 AM
[DisplayDateStart] => Nov 04 2011 10:14
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[59] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626491
[DLU] => 20111212 20:53:39
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/3/2011 10:14:00 AM
[DisplayDateStart] => Dec 12 2011 03:53
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => recyte
)
)
[60] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626932
[DLU] => 20111107 13:59:17
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. and the University of California System Sign Cell Transfer Agreement for Human Embryonic Stem Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/22/2010 8:58:00 AM
[DisplayDateStart] => Nov 07 2011 08:59
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[61] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626933
[DLU] => 20111107 14:00:02
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign Marketing Agreement for ACTCellerate™ Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/9/2010 8:59:00 AM
[DisplayDateStart] => Nov 07 2011 09:00
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[62] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626934
[DLU] => 20111107 14:00:34
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Plans Warrant Distribution to Shareholders
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/3/2010 9:00:00 AM
[DisplayDateStart] => Nov 07 2011 09:00
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[63] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626936
[DLU] => 20111107 14:01:31
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. and the California Institute for Regenerative Medicine Sign Distribution Agreement for GMP-Compliant Human Embryonic Stem Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/29/2010 9:00:00 AM
[DisplayDateStart] => Nov 07 2011 09:01
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[64] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626939
[DLU] => 20111107 14:02:08
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Third Quarter 2010 Financial Results and Recent Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/15/2010 9:01:00 AM
[DisplayDateStart] => Nov 07 2011 09:02
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[65] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626960
[DLU] => 20111107 14:03:10
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's CEO Michael West to Present Keynote Address at BIT Life Sciences' 3rd Annual World Congress of Regenerative Medicine & Stem Cells 2010 in Shanghai, China
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/10/2010 9:02:00 AM
[DisplayDateStart] => Nov 07 2011 09:03
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[66] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626961
[DLU] => 20111107 14:04:19
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Final Results of Warrant Exercises
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/4/2010 9:03:00 AM
[DisplayDateStart] => Nov 07 2011 09:04
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[67] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626975
[DLU] => 20111107 14:05:19
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Awarded $733,000 in Grants Under Qualifying Therapeutic Discovery Project Program
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/3/2010 9:04:00 AM
[DisplayDateStart] => Nov 07 2011 09:05
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[68] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1487203
[DLU] => 20111103 16:47:21
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Expands Corporate Headquarters
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/26/2010 9:07:29 AM
[DisplayDateStart] => Nov 03 2011 12:47
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[69] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1486146
[DLU] => 20111103 16:47:44
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's CEO Michael West Presents 12 New ACTCellerateTM
Cell Lines and New PureStemTM Products Slated
for Launch in 2011 at GTCbio Stem Cell Conference Today
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/22/2010 9:03:47 AM
[DisplayDateStart] => Nov 03 2011 12:47
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[70] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1482707
[DLU] => 20111104 12:38:56
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime's CEO Michael West to Speak at GTCbio and Unveil 12 New
Diverse Cell Lines to be Launched November 1, 2010
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/14/2010 9:04:06 AM
[DisplayDateStart] => Nov 04 2011 08:38
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[71] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1481410
[DLU] => 20111104 12:39:11
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Stock Ticker Symbol Change and Extension of Warrant
Expiration Date
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/12/2010 8:04:14 AM
[DisplayDateStart] => Nov 04 2011 08:39
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[72] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1480850
[DLU] => 20111212 20:47:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Cell Cure Neurosciences Ltd., a Subsidiary of BioTime, Inc. and Hadasit Bio Holdings Ltd., Enters into an Exclusive License Option Agreement with Teva Pharmaceutical Industries Ltd.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/10/2010 9:19:00 PM
[DisplayDateStart] => Dec 12 2011 03:47
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => cell cure
)
)
[73] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1480849
[DLU] => 20111212 20:47:34
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Cell Cure Neurosciences' Shareholders Will Invest $7.1 M in the Company's Development of Innovative Stem Cell Treatments for Neural and Retinal Diseases
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/10/2010 9:08:00 PM
[DisplayDateStart] => Dec 12 2011 03:47
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => cell cure
)
)
[74] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1472010
[DLU] => 20111104 12:40:07
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West and CMO Dr. David Jin to Present Keynote
Addresses at The Sixth Chinese Congress in Regenerative Medicine and
Stem Cell Therapy in Suzhou, P.R. China
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/16/2010 8:32:08 AM
[DisplayDateStart] => Nov 04 2011 08:40
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[75] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1470182
[DLU] => 20111104 12:40:54
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at Stem Cells USA &
Regenerative Medicine Congress 2010
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/13/2010 8:32:39 AM
[DisplayDateStart] => Nov 04 2011 08:40
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[76] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1468786
[DLU] => 20111104 12:41:46
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Executive Management Changes
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/8/2010 11:37:59 PM
[DisplayDateStart] => Nov 04 2011 08:41
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[77] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1464005
[DLU] => 20111104 12:42:31
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime to Launch Seven New Embryonic Progenitor Cell Lines on
September 1, 2010
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/26/2010 3:29:59 PM
[DisplayDateStart] => Nov 04 2011 08:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[78] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1461760
[DLU] => 20111104 12:43:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Raises $9.2 Million in Warrant Discount Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/19/2010 8:08:44 PM
[DisplayDateStart] => Nov 04 2011 08:43
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[79] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1460309
[DLU] => 20111104 12:44:06
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Second Quarter 2010 Financial Results and Recent
Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/16/2010 5:31:32 PM
[DisplayDateStart] => Nov 04 2011 08:44
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[80] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1450194
[DLU] => 20111104 12:44:21
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Addition of New Stem Cell Lines to Its Product
Portfolio
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/21/2010 12:53:54 PM
[DisplayDateStart] => Nov 04 2011 08:44
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[81] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1449027
[DLU] => 20111104 12:42:01
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Provides Financial Information about Its Acquisition of
ES Cell International Pte Ltd.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/19/2010 10:48:39 AM
[DisplayDateStart] => Nov 04 2011 08:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[82] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1445999
[DLU] => 20111104 12:42:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at the Agora Financial
Investment Symposium 2010
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/9/2010 8:30:46 AM
[DisplayDateStart] => Nov 04 2011 08:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[83] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1444814
[DLU] => 20111104 12:43:06
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Passing of Board Director Dr. Robert N. Butler
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/6/2010 6:44:25 PM
[DisplayDateStart] => Nov 04 2011 08:43
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[84] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1439720
[DLU] => 20111104 12:44:44
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Commences Warrant Discount Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/18/2010 10:04:50 AM
[DisplayDateStart] => Nov 04 2011 08:44
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[85] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1437842
[DLU] => 20111104 12:45:01
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results of Vote at Annual Shareholders Meeting
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/14/2010 4:05:50 PM
[DisplayDateStart] => Nov 04 2011 08:45
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[86] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1437462
[DLU] => 20111104 12:42:49
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Set to Join Russell 3000 Index
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/13/2010 3:55:59 PM
[DisplayDateStart] => Nov 04 2011 08:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[87] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1436870
[DLU] => 20111104 12:40:21
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop
Treatments for Orthopedic Conditions Using Stem Cell Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/10/2010 3:02:07 PM
[DisplayDateStart] => Nov 04 2011 08:40
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[88] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1436072
[DLU] => 20111104 12:52:58
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at the Inaugural Jefferies
Global Life Sciences Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/8/2010 7:19:34 PM
[DisplayDateStart] => Nov 04 2011 08:52
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[89] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1431860
[DLU] => 20111104 12:53:33
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Adds Five New Stem Cell Lines to Its Product Portfolio
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/27/2010 8:45:49 AM
[DisplayDateStart] => Nov 04 2011 08:53
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[90] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1429974
[DLU] => 20111104 12:53:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at GTCbio 6th Annual Stem
Cell Research & Therapeutics Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/21/2010 9:01:45 AM
[DisplayDateStart] => Nov 04 2011 08:53
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[91] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1424885
[DLU] => 20111104 12:54:20
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Receipt of $8 Million from Early Exercise of
Warrants
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/10/2010 4:55:54 PM
[DisplayDateStart] => Nov 04 2011 08:54
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[92] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1422608
[DLU] => 20111104 12:54:59
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces First Quarter 2010 Financial Results and Recent
Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/5/2010 8:50:54 AM
[DisplayDateStart] => Nov 04 2011 08:54
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[93] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1421162
[DLU] => 20111104 12:55:34
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces Completion of ES Cell International Pte Ltd
Acquisition
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/3/2010 9:15:46 AM
[DisplayDateStart] => Nov 04 2011 08:55
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[94] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1420328
[DLU] => 20111104 12:55:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Provides Additional Information on Acquisition of
Promissory Notes in Connection with Planned Acquisition of ES Cell
International Pte Ltd.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/29/2010 4:32:37 PM
[DisplayDateStart] => Nov 04 2011 08:55
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[95] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1420122
[DLU] => 20111212 20:48:38
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces Agreement to Acquire ES Cell International
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/29/2010 12:59:00 PM
[DisplayDateStart] => Dec 12 2011 03:48
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => es cell
)
)
[96] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1402643
[DLU] => 20111212 20:54:14
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Reports Peer-Reviewed Scientific Publication on the Reversal of the Developmental Aging of Normal Human Cells
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/16/2010 7:04:00 AM
[DisplayDateStart] => Dec 12 2011 03:54
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => recyte
)
)
[97] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1401026
[DLU] => 20111104 12:55:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Fourth Quarter and Fiscal Year-End 2009 Financial
Results and Recent Corporate Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/10/2010 8:05:41 AM
[DisplayDateStart] => Nov 04 2011 08:55
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[98] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1384115
[DLU] => 20111104 12:53:15
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Reports Results from Independent Hextend(R)
Study
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 2/5/2010 7:32:16 AM
[DisplayDateStart] => Nov 04 2011 08:53
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[99] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626997
[DLU] => 20111107 14:13:58
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Subsidiary OncoCyte Corporation Receives Second $2,000,000 Equity Tranche; BioTime Plans Additional $2,250,000 Investment
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/7/2010 9:13:00 AM
[DisplayDateStart] => Nov 07 2011 09:13
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[100] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1626999
[DLU] => 20111107 14:14:28
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Commences Shipment of Stem Cell Research Products to Millipore
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/5/2010 9:13:00 AM
[DisplayDateStart] => Nov 07 2011 09:14
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[101] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627018
[DLU] => 20111107 14:42:11
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/4/2009 9:41:00 AM
[DisplayDateStart] => Nov 07 2011 09:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[102] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627019
[DLU] => 20111107 14:42:47
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/24/2009 9:42:00 AM
[DisplayDateStart] => Nov 07 2011 09:42
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[103] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627021
[DLU] => 20111107 14:44:29
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/12/2009 9:43:00 AM
[DisplayDateStart] => Nov 07 2011 09:44
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[104] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627020
[DLU] => 20111107 14:43:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/12/2009 9:42:00 AM
[DisplayDateStart] => Nov 07 2011 09:43
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[105] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627024
[DLU] => 20111107 14:47:31
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/22/2009 9:46:00 AM
[DisplayDateStart] => Nov 07 2011 09:47
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[106] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627023
[DLU] => 20111107 14:46:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces Approval For NYSE Amex Listing
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/22/2009 9:44:00 AM
[DisplayDateStart] => Nov 07 2011 09:46
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[107] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627025
[DLU] => 20111107 14:48:18
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => New BioTime Subsidiary, OncoCyte Corporation, Receives $2 Million Equity Financing to Develop Cancer Treatments Using Stem Cell Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/15/2009 9:47:00 AM
[DisplayDateStart] => Nov 07 2011 09:48
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[108] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627027
[DLU] => 20111107 14:48:47
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime to Podcast Presentation at Annual Meeting of Shareholders
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/14/2009 9:48:00 AM
[DisplayDateStart] => Nov 07 2011 09:48
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[109] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627028
[DLU] => 20111212 20:46:00
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. to Form Asian Subsidiary
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/22/2009 9:48:00 AM
[DisplayDateStart] => Dec 12 2011 03:46
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => asia
)
)
[110] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627029
[DLU] => 20111107 14:50:05
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present Keynote Address at China-USA Scientific Forum of Stem Cell and Regenerative Medicine
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/18/2009 9:49:00 AM
[DisplayDateStart] => Nov 07 2011 09:50
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[111] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627030
[DLU] => 20111107 14:50:39
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at 2009 World Stem Cell Summit
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/2/2009 9:50:00 AM
[DisplayDateStart] => Nov 07 2011 09:50
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[112] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627034
[DLU] => 20111107 15:00:07
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Completes Exchange Offer for Revolving Line of Credit Notes
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/24/2009 9:50:00 AM
[DisplayDateStart] => Nov 07 2011 10:00
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[113] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627035
[DLU] => 20111107 15:00:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Appoints Pedro Lichtinger to Its Board of Directors
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/17/2009 10:00:00 AM
[DisplayDateStart] => Nov 07 2011 10:00
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[114] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627036
[DLU] => 20111107 15:01:17
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Appoints Walter Funk Vice President for Stem Cell Research
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/10/2009 10:00:00 AM
[DisplayDateStart] => Nov 07 2011 10:01
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[115] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627044
[DLU] => 20111107 15:01:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Commences Exchange Offer for Revolving Line of Credit Notes
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/5/2009 10:01:00 AM
[DisplayDateStart] => Nov 07 2011 10:01
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[116] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627047
[DLU] => 20111107 15:02:36
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Investors Fund Second $4,000,000 Equity Tranche
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/13/2009 10:01:00 AM
[DisplayDateStart] => Nov 07 2011 10:02
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[117] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627051
[DLU] => 20111107 15:03:13
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Stem Cell Co-marketing Agreement with Millipore
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/9/2009 10:02:00 AM
[DisplayDateStart] => Nov 07 2011 10:03
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[118] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627052
[DLU] => 20111107 15:04:04
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Adds New Members to Its Board of Directors
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/7/2009 10:03:00 AM
[DisplayDateStart] => Nov 07 2011 10:04
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[119] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627054
[DLU] => 20111107 15:04:35
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Raises $4,000,000 in Equity Financing
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/14/2009 10:04:00 AM
[DisplayDateStart] => Nov 07 2011 10:04
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[120] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627055
[DLU] => 20111107 15:05:27
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009 and Discuss New Cell Lines with Cartilage-Forming Potential
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/7/2009 10:04:00 AM
[DisplayDateStart] => Nov 07 2011 10:05
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[121] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627056
[DLU] => 20111107 15:09:13
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Awarded a $4.7 Million Research Grant from the California Institute for Regenerative Medicine
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/30/2009 10:05:00 AM
[DisplayDateStart] => Nov 07 2011 10:09
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[122] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627063
[DLU] => 20111107 15:09:51
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces 2008 Year-End Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/30/2009 10:09:00 AM
[DisplayDateStart] => Nov 07 2011 10:09
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[123] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627075
[DLU] => 20111107 15:28:30
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Launches New Stem Cell Lines in Anticipation of President Obama's Removal of Restrictions on Federal Funding of Embryonic Stem Cell Research
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/21/2009 10:10:00 AM
[DisplayDateStart] => Nov 07 2011 10:28
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[124] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627076
[DLU] => 20111107 15:29:46
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Inc. Announces Third Quarter 2008 Financial Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/21/2008 10:28:00 AM
[DisplayDateStart] => Nov 07 2011 10:29
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[125] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627077
[DLU] => 20111107 15:30:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/20/2008 10:29:00 AM
[DisplayDateStart] => Nov 07 2011 10:30
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[126] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627078
[DLU] => 20111107 15:31:41
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Presents Keynote Address at Event Commemorating the 10th Anniversary of the First Derivation of Human Embryonic Stem Cells
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/14/2008 10:30:00 AM
[DisplayDateStart] => Nov 07 2011 10:31
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[127] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627082
[DLU] => 20111107 15:32:28
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Presents at GTCbio Advances in Stem Cell Discoveries Meeting and Announces Launch of New Neural Crest Cell Lines
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/27/2008 10:31:00 AM
[DisplayDateStart] => Nov 07 2011 10:32
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[128] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627083
[DLU] => 20111107 15:33:02
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Collaboration With the International Longevity Center on Regenerative Medicine
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/13/2008 10:32:00 AM
[DisplayDateStart] => Nov 07 2011 10:33
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[129] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627084
[DLU] => 20111107 15:33:32
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Presents at Tecan Symposium 2008
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/18/2008 10:33:00 AM
[DisplayDateStart] => Nov 07 2011 10:33
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[130] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627085
[DLU] => 20111107 15:34:05
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Conference Call Will Discuss Its Recent Acquisition of Stem Cell Technology Licenses
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/11/2008 10:33:00 AM
[DisplayDateStart] => Nov 07 2011 10:34
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[131] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627086
[DLU] => 20111107 15:36:25
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc.'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS and Embryonic Stem Cell Differentiation Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/21/2008 10:34:00 AM
[DisplayDateStart] => Nov 07 2011 10:36
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[132] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627087
[DLU] => 20111107 15:37:00
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Inc. Announces Second Quarter 2008 Financial Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/15/2008 10:36:00 AM
[DisplayDateStart] => Nov 07 2011 10:36
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[133] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627088
[DLU] => 20111107 15:37:29
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/6/2008 10:37:00 AM
[DisplayDateStart] => Nov 07 2011 10:37
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[134] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627105
[DLU] => 20111107 16:06:08
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Embryome Sciences, Inc. Acquires Exclusive License for ACTCellerate Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/16/2008 10:37:00 AM
[DisplayDateStart] => Nov 07 2011 11:06
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[135] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627107
[DLU] => 20111107 16:07:02
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/27/2008 11:06:00 AM
[DisplayDateStart] => Nov 07 2011 11:07
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[136] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627108
[DLU] => 20111107 16:07:35
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/25/2008 11:07:00 AM
[DisplayDateStart] => Nov 07 2011 11:07
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[137] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627109
[DLU] => 20111107 16:08:44
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Inc. Announces First Quarter 2008 Financial Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/19/2008 11:07:00 AM
[DisplayDateStart] => Nov 07 2011 11:08
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[138] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627110
[DLU] => 20111107 16:09:07
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Presents at European Stem Cells & Regenerative Medicine Congress 2008
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/15/2008 11:08:00 AM
[DisplayDateStart] => Nov 07 2011 11:09
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[139] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627111
[DLU] => 20111107 16:09:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael West Presents at 2008 Seoul Digital Forum
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/6/2008 11:09:00 AM
[DisplayDateStart] => Nov 07 2011 11:09
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[140] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627112
[DLU] => 20111107 16:11:02
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Opens New GMP Laboratory for Production of Embryonic Stem Cell Technology Products
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/16/2008 11:09:00 AM
[DisplayDateStart] => Nov 07 2011 11:11
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[141] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627113
[DLU] => 20111107 16:12:11
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces 2007 Year-End Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/15/2008 11:11:00 AM
[DisplayDateStart] => Nov 07 2011 11:12
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[142] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627115
[DLU] => 20111107 16:14:06
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Signs Letter of Intent With International Stem Cell Corporation for Joint Production and Distribution of Stem Cell Products
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/3/2008 11:12:00 AM
[DisplayDateStart] => Nov 07 2011 11:14
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[143] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627116
[DLU] => 20111107 16:14:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Receives Funds From The Life Extension Foundation for Application in Regenerative Medicine and Aging
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 3/11/2008 11:14:00 AM
[DisplayDateStart] => Nov 07 2011 11:14
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[144] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627118
[DLU] => 20111107 16:16:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Licenses Human Embryonic Stem Cell Technology from the Wisconsin Alumni Research Foundation
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/9/2008 11:14:00 AM
[DisplayDateStart] => Nov 07 2011 11:16
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[145] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1627123
[DLU] => 20111107 16:17:05
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime CEO Dr. Michael D. West to Lecture on Regenerative Medicine and Age Related Degenerative Disease
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/7/2008 11:16:00 AM
[DisplayDateStart] => Nov 07 2011 11:17
[DisplayDateEnd] => Dec 31 9999 12:00
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[146] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1088186
[DLU] => 20071218 11:30:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces Plan to Map the Human Embryome
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/18/2007 6:31:00 AM
[DisplayDateStart] => Dec 18 2007 06:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[147] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1086687
[DLU] => 20071212 17:37:00
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. Announces the Formation of Embryome Sciences, Inc. for the Development and Commercialization of Stem Cell Technology
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/12/2007 12:37:00 PM
[DisplayDateStart] => Dec 12 2007 12:37
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[148] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1078725
[DLU] => 20071115 19:42:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Third Quarter 2007
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/15/2007 2:43:00 PM
[DisplayDateStart] => Nov 15 2007 02:43
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[149] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1073002
[DLU] => 20071106 10:01:13
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. to Present Plans for Regenerative Medicine at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/6/2007 5:01:00 AM
[DisplayDateStart] => Nov 06 2007 05:01
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[150] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1071731
[DLU] => 20071102 15:12:03
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Joint Hypothermic Medicine Study With Argonne National Laboratory
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/2/2007 8:01:00 AM
[DisplayDateStart] => Nov 02 2007 08:01
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[151] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1070617
[DLU] => 20071031 20:41:29
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime, Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/31/2007 4:41:00 PM
[DisplayDateStart] => Oct 31 2007 04:41
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[152] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1066049
[DLU] => 20071023 12:31:23
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/23/2007 8:31:00 AM
[DisplayDateStart] => Oct 23 2007 08:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[153] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1064223
[DLU] => 20071017 19:11:50
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces New Line of Credit
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/17/2007 3:12:00 PM
[DisplayDateStart] => Oct 17 2007 03:12
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[154] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1061942
[DLU] => 20071011 23:00:44
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Names Dr. Michael D. West as CEO and Announces Entry Into Stem Cell Research and Regenerative Medicine
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/11/2007 7:01:00 PM
[DisplayDateStart] => Oct 11 2007 07:01
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[155] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1041021
[DLU] => 20070815 22:00:13
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Second Quarter 2007
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/15/2007 6:00:00 PM
[DisplayDateStart] => Aug 15 2007 06:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[156] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1015223
[DLU] => 20070613 21:25:03
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime To Seek New Marketing Partners For PentaLyte(R)
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/13/2007 5:25:00 PM
[DisplayDateStart] => Jun 13 2007 05:25
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[157] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1003153
[DLU] => 20070516 16:10:40
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for First Quarter 2007
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/16/2007 12:11:00 PM
[DisplayDateStart] => May 16 2007 12:11
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[158] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 987591
[DLU] => 20070419 16:58:53
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces 2006 Year-End Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/19/2007 12:59:00 PM
[DisplayDateStart] => Apr 19 2007 12:59
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[159] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 939991
[DLU] => 20061207 13:02:25
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces a Phase II Clinical Trial of Hextend(R) in Japan
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/7/2006 8:02:00 AM
[DisplayDateStart] => Dec 07 2006 08:02
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[160] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 931695
[DLU] => 20061116 03:10:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Third Quarter 2006
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/15/2006 2:10:00 PM
[DisplayDateStart] => Nov 15 2006 02:10
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[161] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 896194
[DLU] => 20060816 10:30:25
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Second Quarter 2006
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/16/2006 6:30:00 AM
[DisplayDateStart] => Aug 16 2006 06:30
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[162] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 873741
[DLU] => 20060619 16:37:30
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 1
)
[Title] => BioTime Announces Second Quarter Hextend Revenue
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/19/2006 12:38:00 PM
[DisplayDateStart] => Jun 19 2006 12:38
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[163] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 857331
[DLU] => 20060516 15:54:45
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for First Quarter 2006
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/16/2006 11:55:00 AM
[DisplayDateStart] => May 16 2006 11:55
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[164] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 843607
[DLU] => 20060418 10:31:01
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Fourth Quarter and Fiscal Year-End Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/18/2006 6:31:00 AM
[DisplayDateStart] => Apr 18 2006 06:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[165] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 842915
[DLU] => 20060414 14:20:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Company Profile for BioTime, Inc.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/14/2006 10:20:00 AM
[DisplayDateStart] => Apr 14 2006 10:20
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[166] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 840525
[DLU] => 20060410 10:30:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces License Agreement for China and Taiwan
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/10/2006 6:31:00 AM
[DisplayDateStart] => Apr 10 2006 06:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[167] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 798687
[DLU] => 20051222 19:49:00
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Raises $1,787,145 in Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/22/2005 2:39:00 PM
[DisplayDateStart] => Dec 22 2005 02:39
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[168] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 798052
[DLU] => 20051221 02:41:28
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Sublicense Arrangement for Japan With Maruishi Pharmaceutical Co., Ltd.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/20/2005 9:41:00 PM
[DisplayDateStart] => Dec 20 2005 09:41
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[169] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 790954
[DLU] => 20051129 18:02:49
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Amends Terms of Subscription Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/29/2005 1:03:00 PM
[DisplayDateStart] => Nov 29 2005 01:03
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[170] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 782893
[DLU] => 20051115 13:03:01
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Third Quarter 2005
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/15/2005 8:03:00 AM
[DisplayDateStart] => Nov 15 2005 08:03
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[171] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 774606
[DLU] => 20051027 21:58:35
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Commences Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/27/2005 5:59:00 PM
[DisplayDateStart] => Oct 27 2005 05:59
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[172] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 751909
[DLU] => 20050901 20:04:14
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Plans Rights Offering Backed by Standby Guaranty
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 9/1/2005 4:04:00 PM
[DisplayDateStart] => Sep 01 2005 04:04
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[173] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 743685
[DLU] => 20050816 14:17:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for Second Quarter 2005
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/16/2005 10:18:00 AM
[DisplayDateStart] => Aug 16 2005 10:18
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[174] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 730565
[DLU] => 20050715 13:04:25
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces New Trading Symbols
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/14/2005 9:36:00 PM
[DisplayDateStart] => Jul 14 2005 09:36
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[175] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 729060
[DLU] => 20050712 12:04:21
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces New Patent in China
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/12/2005 8:04:00 AM
[DisplayDateStart] => Jul 12 2005 08:04
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[176] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 727294
[DLU] => 20050707 11:31:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Delisting From AMEX; Common Stock and Warrants to Be Quoted on OTC Bulletin Board
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/7/2005 7:31:00 AM
[DisplayDateStart] => Jul 07 2005 07:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[177] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 722182
[DLU] => 20050620 16:34:49
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Moves to New Headquarters
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/20/2005 12:35:00 PM
[DisplayDateStart] => Jun 20 2005 12:35
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[178] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 710662
[DLU] => 20050517 11:30:39
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Results for First Quarter 2005
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/17/2005 7:31:00 AM
[DisplayDateStart] => May 17 2005 07:31
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[179] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 702279
[DLU] => 20050427 20:50:04
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Appeal of AMEX Determination
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/27/2005 4:50:00 PM
[DisplayDateStart] => Apr 27 2005 04:50
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[180] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 693397
[DLU] => 20050408 11:00:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Begins PentaLyte Phase II Clinical Trial
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/8/2005 7:01:00 AM
[DisplayDateStart] => Apr 08 2005 07:01
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[181] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 690906
[DLU] => 20050401 12:30:25
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Fourth Quarter and Fiscal Year-End Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/1/2005 7:30:00 AM
[DisplayDateStart] => Apr 01 2005 07:30
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[182] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 646543
[DLU] => 20041122 15:09:05
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Third Quarter Results
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/16/2004 1:33:00 PM
[DisplayDateStart] => Nov 16 2004 01:33
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[183] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 646544
[DLU] => 20041122 15:09:13
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Valeta A. Gregg, Ph.D., J.D. Joins BioTime, Inc. Board Of Directors
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 11/2/2004 6:48:00 PM
[DisplayDateStart] => Nov 02 2004 06:48
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[184] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653032
[DLU] => 20041216 15:43:12
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Increased Revenues For Second Quarter 2004
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/13/2004 12:00:00 AM
[DisplayDateStart] => Aug 13 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[185] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653031
[DLU] => 20041208 21:03:08
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Regulatory Approval of Hextend(R) in South Korea; Receives Second License Fee From CJ Corp.
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/7/2004 12:00:00 AM
[DisplayDateStart] => Jul 07 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[186] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653010
[DLU] => 20041208 20:51:21
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Mourns Passing of Founder
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/23/2004 12:00:00 AM
[DisplayDateStart] => Jun 23 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[187] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653023
[DLU] => 20041208 21:00:17
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Appoints Jeffrey Nickel, Ph.D. Vice President of Business Development and Marketing
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/1/2004 12:00:00 AM
[DisplayDateStart] => Jun 01 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[188] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653021
[DLU] => 20041208 20:59:41
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Strong Royalty Revenue Increase for First Quarter 2004
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/13/2004 12:00:00 AM
[DisplayDateStart] => May 13 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[189] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653020
[DLU] => 20041208 21:01:22
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Awarded NIH Grant to Aid HetaCool Development
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/21/2004 12:00:00 AM
[DisplayDateStart] => Apr 21 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[190] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653019
[DLU] => 20041208 20:57:46
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Announces Repayment Of Debentures; Eliminates All Long-Term Debt
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 2/11/2004 12:00:00 AM
[DisplayDateStart] => Feb 11 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[191] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653018
[DLU] => 20041208 20:57:09
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Completes Rights Offer, Announces That Rights Offer Was Heavily Oversubscribed
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/22/2004 12:00:00 AM
[DisplayDateStart] => Jan 22 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[192] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653017
[DLU] => 20041208 20:56:08
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Rights Offer Extended to January 21, 2004
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/13/2004 12:00:00 AM
[DisplayDateStart] => Jan 13 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[193] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653015
[DLU] => 20041208 20:55:35
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Further Extends Expiration Date of Subscription Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 1/6/2004 12:00:00 AM
[DisplayDateStart] => Jan 06 2004 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[194] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653014
[DLU] => 20041208 20:53:40
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Extends Expiration Date of Subscription Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/29/2003 12:00:00 AM
[DisplayDateStart] => Dec 29 2003 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[195] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653013
[DLU] => 20041208 20:53:05
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Commences Rights Offer
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/11/2003 12:00:00 AM
[DisplayDateStart] => Dec 11 2003 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[196] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653012
[DLU] => 20041208 20:52:16
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Plans Rights Offering Backed by Standby Guaranty
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/2/2003 12:00:00 AM
[DisplayDateStart] => Oct 02 2003 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[197] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653009
[DLU] => 20041208 20:49:42
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Meets With Its Industry Partners in Asia
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 6/4/2003 12:00:00 AM
[DisplayDateStart] => Jun 04 2003 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[198] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653008
[DLU] => 20041208 20:48:48
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => CJ Corp. and BioTime Sign a License Agreement for Korea
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 4/14/2003 12:00:00 AM
[DisplayDateStart] => Apr 14 2003 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[199] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653007
[DLU] => 20041208 20:47:35
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Asia-Based Multinationals to Help with BioTime's Overseas Expansion
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 12/31/2002 12:00:00 AM
[DisplayDateStart] => Dec 31 2002 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[200] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653006
[DLU] => 20041208 20:46:29
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Dr. Michael D. West Nominated to Join BioTime's Board of Directors
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 10/1/2002 12:00:00 AM
[DisplayDateStart] => Oct 01 2002 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[201] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653004
[DLU] => 20041208 20:47:52
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime Raises Over $2 Million in a Private Placement as Quarterly Revenues Grow
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 8/13/2002 12:00:00 AM
[DisplayDateStart] => Aug 13 2002 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
[202] => SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 653003
[DLU] => 20041208 20:44:59
[ArchiveStatus] => Archive
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => Hextend Approved for Sale in Canada
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 7/9/2002 12:00:00 AM
[DisplayDateStart] => Jul 09 2002 12:00
[DisplayDateEnd] => Dec 05 2029 01:43
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
)
)
)
SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1699020
[DLU] => 20120523 12:45:29
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.08
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/23/2012 8:45:29 AM
[DisplayDateStart] => May 23 2012 08:45
[DisplayDateEnd] => May 23 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
SimpleXMLElement Object
(
[@attributes] => Array
(
[ReleaseID] => 1698562
[DLU] => 20120522 12:45:22
[ArchiveStatus] => Current
[RNSSource] =>
[ContainerId] =>
[Type] => 2
)
[Title] => BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases
[ExternalURL] => SimpleXMLElement Object
(
)
[Date] => 5/22/2012 8:45:21 AM
[DisplayDateStart] => May 22 2012 08:45
[DisplayDateEnd] => May 22 2032 12:45
[ContentNetworkingLinks] => SimpleXMLElement Object
(
)
[Categories] => SimpleXMLElement Object
(
[Category] => NA
)
)
Latest Video
Product Development Update: Renevia(TM)
See More Videos
Investors
BioTime has been a publicly traded company since 1992. Visit our investor relations website to learn more about investing in this biotechnology … Learn more
Buy Products
Contact Us
sitemap +
Web Design by PoleVault Media